Fumiyoshi Ohyanagi

Fumiyoshi Ohyanagi

UNVERIFIED PROFILE

Are you Fumiyoshi Ohyanagi?   Register this Author

Register author
Fumiyoshi Ohyanagi

Fumiyoshi Ohyanagi

Publications by authors named "Fumiyoshi Ohyanagi"

Are you Fumiyoshi Ohyanagi?   Register this Author

39Publications

864Reads

12Profile Views

Lung Adenocarcinoma with Lynch Syndrome and the Response to Nivolumab.

Intern Med 2019 15;58(10):1479-1484. Epub 2019 May 15.

Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2169/internalmedicine.1673-18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548921PMC
June 2019

Characterization of Computed Tomography Imaging of Rearranged During Transfection-rearranged Lung Cancer.

Clin Lung Cancer 2018 09 10;19(5):435-440.e1. Epub 2018 May 10.

Department of Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.04.006DOI Listing
September 2018

Dramatic response to alectinib in inflammatory myofibroblastic tumor with anaplastic lymphoma kinase fusion gene.

Jpn J Clin Oncol 2017 Dec;47(12):1189-1192

Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyx133DOI Listing
December 2017

EBUS-TBNA as a Promising Method for the Evaluation of Tumor PD-L1 Expression in Lung Cancer.

Clin Lung Cancer 2017 09 22;18(5):527-534.e1. Epub 2016 Dec 22.

Division of Pathology, The Cancer Institute, Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.12.002DOI Listing
September 2017

Prognostic significance of CpG island methylator phenotype in surgically resected small cell lung carcinoma.

Cancer Sci 2016 Mar 19;107(3):320-5. Epub 2016 Feb 19.

Division of Pathology, The Cancer Institute, Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.12876DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814245PMC
March 2016

Sorafenib treatment for patients with RET fusion-positive non-small cell lung cancer.

Lung Cancer 2016 Mar 30;93:43-6. Epub 2015 Dec 30.

Department of Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ward, Tokyo 135-8550, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.12.011DOI Listing
March 2016

Distinct Characteristics of Small Cell Lung Cancer Correlate With Central or Peripheral Origin: Subtyping Based on Location and Expression of Transcription Factor TTF-1.

Medicine (Baltimore) 2015 Dec;94(51):e2324

From the Division of Pathology, The Cancer Institute, Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research (JFCR) (EM, NM, HO, HN, YI); Thoracic Center, The Cancer Institute Hospital, JFCR, Tokyo (FO, MN, SO); and Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (EM, MI).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000002324DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697988PMC
December 2015

Prognostic value of (18) F-fluoroazomycin arabinoside PET/CT in patients with advanced non-small-cell lung cancer.

Cancer Sci 2015 Nov 7;106(11):1554-60. Epub 2015 Oct 7.

Department of Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.12771DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714693PMC
November 2015

Phase I study of the anti-MET antibody onartuzumab in patients with solid tumors and MET-positive lung cancer.

Invest New Drugs 2015 Jun 18;33(3):632-40. Epub 2015 Mar 18.

Department of Thoracic Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo, 135-8550, Japan,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-015-0227-5
Publisher Site
http://dx.doi.org/10.1007/s10637-015-0227-5DOI Listing
June 2015

Phase II study of docetaxel-plus-bevacizumab combination therapy in patients previously treated for advanced non-squamous non-small cell lung cancer.

Anticancer Res 2014 Sep;34(9):5153-8

Department of Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan

View Article

Download full-text PDF

Source
September 2014

Phase II study of erlotinib for acquired resistance to gefitinib in patients with advanced non-small cell lung cancer.

Anticancer Res 2014 Apr;34(4):1975-81

Department of Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan.

View Article

Download full-text PDF

Source
April 2014

A feasibility study of carboplatin plus irinotecan treatment for elderly patients with extensive disease small-cell lung cancer.

Jpn J Clin Oncol 2014 Feb 13;44(2):116-21. Epub 2013 Dec 13.

*Department of Respiratory Medicine and Medical Oncology, Yokohama Municipal Citizen's Hospital, 56 Okazawa-cho, Hodogaya-ku, Yokohama, Kanagawa 240-8555, Japan.

View Article

Download full-text PDF

Source
https://academic.oup.com/jjco/article-lookup/doi/10.1093/jjc
Publisher Site
http://dx.doi.org/10.1093/jjco/hyt195DOI Listing
February 2014

[A case of adenocarcinoma of the lung with a pulmonary thromboembolism which improved with gefitinib].

Nihon Kokyuki Gakkai Zasshi 2011 Apr;49(4):282-6

Japanese Foundation for Cancer Research, Thoracic Oncology Center.

View Article

Download full-text PDF

Source
April 2011

Phase II trial of gemcitabine and irinotecan in previously treated patients with small-cell lung cancer.

Cancer Chemother Pharmacol 2008 Mar 5;61(3):503-8. Epub 2007 May 5.

Thoracic Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake 3-10-6, Koto-ku, Tokyo 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-007-0496-6DOI Listing
March 2008

Gefitinib efficacy associated with multiple expression of HER family in non-small cell lung cancer.

Anticancer Res 2006 Sep-Oct;26(5B):3761-5

Thoracic Oncology Center, Cancer Institute Hospital, Ariake 3-10-6, Koto-ku, Tokyo 135-8550, Japan.

View Article

Download full-text PDF

Source
December 2006

Postoperative ischemic change in bronchial stumps after primary lung cancer resection.

Eur J Cardiothorac Surg 2006 Jul 26;30(1):172-6. Epub 2006 May 26.

Department of Thoracic Surgical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejcts.2006.03.047DOI Listing
July 2006

Antipyrine test predicts pharmacodynamics in docetaxel and cisplatin combination chemotherapy.

Lung Cancer 2005 Aug;49(2):245-51

Division of Internal Medicine, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Kami-ikebukuro 1-37-1, Toshima-ku, Tokyo 170-8455, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2005.02.007DOI Listing
August 2005

Phase I study of combination chemotherapy with gemcitabine and irinotecan for non-small cell lung cancer.

Lung Cancer 2005 Apr;48(1):115-9

Division of Internal Medicine, Cancer Institute Hospital, Japanese Foundation For Cancer Research, Kami-ikebukuro 1-37-1, Toshima-ku, Tokyo 170-8455, Japan.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016950020400478
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2004.09.006DOI Listing
April 2005

Acute gefitinib-induced pneumonitis.

Int J Clin Oncol 2004 Oct;9(5):406-9

Department of Clinical Oncology, Saitama Medical School, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama 350-0451, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-004-0418-0DOI Listing
October 2004